Combined hyperlipidemia is defined as increased low-density lipoprotein (LDL) cholesterol, decreased high-density lipoprotein (HDL) cholesterol, and increased triglyceride levels.

Hyperlipidemia was identified in 1196 of the participants included in this study. The authors tested 5 different machine learning models to correctly predict the incidence of hyperlipidemia.

In two phase 2b trials, RNA interference agents were associated with reductions in triglycerides compared with placebo for patients with mixed hyperlipidemia.The final results of the MUIR trial of ...

Hyperlipidemia in the Elderly - Medscape - Apr 15, 2003. Tables. References. Authors and Disclosures. Authors and Disclosures Author(s) Mark E Williams, MD .

Overall, we found that rates of hyperlipidemia screening and statin prescription were suboptimal; the gaps were large enough to recommend broad, rather than targeted, efforts to close them.

Hyperlipidemia is an established risk factor for cardiovascular disease, but its strength as a risk factor for stroke is less clear. Indeed, in some studies low cholesterol levels have been ...

Among secondary outcomes, hyperlipidemia did not affect the hospital length of stay or cost. Several factors increased the hospital length of stay which included any history of coronary artery disease ...

Out of 100 adults infected with COVID-19, anywhere between one and four could end up with high cholesterol as a result. Experts share how to protect yourself.

PASADENA, Calif., May 28, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced results from the Phase 2b double blind, randomized MUIR study of investigational plozasiran (formerly ...